Polymorphisms in the methylenetetrahydrofolate reductase gene and prostate cancer risk. [electronic resource]
- International journal of oncology Nov 2004
- 1465-71 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
1019-6439
Aged Aged, 80 and over Case-Control Studies Genetic Predisposition to Disease Humans Male Methylenetetrahydrofolate Reductase (NADPH2)--genetics Middle Aged Odds Ratio Polymorphism, Genetic Prostatic Hyperplasia--genetics Prostatic Neoplasms--etiology Risk Factors